Home › Cohorts › Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease.

Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease. PCB0C53AB7

6 studies · 1,334 curated samples · 684 distinct subject identifiers · 3 shared papers. Grouping rule: shared own-data paper.

Samples CSV (39.9 KB) parquet (130.1 KB) Flag an issue
Age categories
unknown972
adult322
elderly40
Countries
US1,334
Health conditions
liver_disease Liver disease (cirrhosis972
other_disease Other disease / condition196
other_infection Other infection (HIV71
transplant_or_immunocompromised Transplant / immunocompromised (HSCT48
healthy_control Healthy / control47

Studies

studytitlesamplessource
PRJNA912122Lactulose-mediated Bifidobacteria expansion promotes a beneficial fecal metabolite profile that is associated with exclusion of antibiotic-resistant pathogens and improved outcomes in advanced liver disease850gut_all_v1
PRJNA1134172Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality risk196gut_all_v1
PRJNA1184735Fecal butyrate and deoxycholic acid concentrations correlate with mortality in hospitalized patients with liver disease122gut_all_v1
PRJNA842425Alterations of the Microbiome During Critical Illness with short and long term clinical outcomes71gut_all_v1
PRJNA845905Donor Specific Antibodies and the Microbiome in Heart Transplant Patients48gut_all_v1
PRJNA838648Healthy Human Stool Donors from Duchossois Family Institute at University of Chicago47gut_all_v1

Shared papers